Cc1cccc(NC(=O)c2[nH]cnc2C(=O)NCCCCNC(=O)c2nc[nH]c2C(=O)Nc2cccc(C)c2)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?